Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO November 12, 2025
Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO October 14, 2025
Our differentiation is validated by strong, sustainable unit economics: Prenetics CEO October 9, 2025
Inspire Veterinary Partners has a focus on long-term relationship with stakeholders: CEO September 18, 2025
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials June 9, 2025
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO November 22, 2024
Richtech’s mission is to transform the service industry through collaborative robotic solutions: President September 12, 2024
AgEagle’s latest focus is on tailoring products for defense, public safety industries: CEO July 10, 2024
Nasdaq listing is a strategic move aimed at bringing value to Noventiq: CEO Hervé Tessler March 15, 2024
Foremost Lithium’s projects are strategically located to capitalize on growing EV appetite: CEO March 7, 2024
Our focus is on acquiring brands with authentic founder stories: DayDayCook CEO Norma Chu March 6, 2024
